Home › Mataas na Presyon ng Dugo › Texas › Dallas
Pag-aaral pangklinika para sa Mataas na Presyon ng Dugo sa Dallas, TX
16 pag-aaral para sa Mataas na Presyon ng Dugo ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Dallas (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Nagre-recruit
- Baylor Scott & White Research Institute, Dallas
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Nagre-recruitPhase 2
- Retension Clinical Site, Dallas
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
- Soltero Cardiovascular Research Center, Dallas
- North Texas Endocrine Center, Dallas
- Southwest Family Medicine Associates, Dallas
- at 1 pa
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Nagre-recruitPhase 3
- Cedar Health Research - Texas Native Health, Dallas
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Nagre-recruitPhase 3
- Research Site, Dallas
- Research Site, Dallas
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Nagre-recruitPhase 3
- Clinical Trial Site, Dallas
- Clinical Trial Site, Dallas
- Clinical Trial Site, Dallas
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
- University of Texas Southwestern Medical Center, Dallas
IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Parkland Hospital, Dallas
Global Paradise System US Post Approval Study
Nagre-recruitObservasyonal na pag-aaral
- Dallas VAMC, Dallas
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Nagre-recruitObservasyonal na pag-aaral
- UT Southwestern Medical Center, Dallas
Polypill for Prevention of Cardiomyopathy
Nagre-recruitPhase 1/2
- UT Southwestern Medical Center, Dallas
A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
Nagre-recruit
- Zenos Clinical Research, Dallas
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
Nagre-recruit
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
SPYRAL GEMINI Pilot Study
Nagre-recruit
- Baylor Heart & Vascular Hospital, Dallas
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
Nagre-recruit
- UT Southwestern Medical Center, Dallas
Preventing Cognitive Decline by Reducing BP Target Trial
Nagre-recruit
- UT Southwestern Medical Center, Dallas
Pag-aaral para sa Mataas na Presyon ng Dugo sa ibang lungsod
- Chicago, IL21 pag-aaral
- Boston, MA21 pag-aaral
- Nashville, TN13 pag-aaral
- Birmingham, AL11 pag-aaral
- Houston, TX11 pag-aaral
- Durham, NC10 pag-aaral
- Atlanta, GA10 pag-aaral
- Tucson, AZ10 pag-aaral
- New York City, NY9 pag-aaral
- Miami, FL9 pag-aaral
- Baltimore, MD9 pag-aaral
- Cleveland, OH8 pag-aaral
Iba pang pag-aaral sa Dallas
- Kanser sa Suso55 pag-aaral
- Non-Small Cell Lung Cancer52 pag-aaral
- Metastatic Cancer42 pag-aaral
- Pagkabigo ng Puso42 pag-aaral
- Kanser (lahat ng uri)37 pag-aaral
- Kanser sa Prostate36 pag-aaral
- Colorectal Cancer33 pag-aaral
- Obesity30 pag-aaral
- Kanser sa Ovary28 pag-aaral
- Kanser sa Baga27 pag-aaral
- Kanser sa Pantog27 pag-aaral
- Kanser ng Endometrium24 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.